Eli Lilly said preliminary data from a late-stage study showed its weight-loss drug significantly reduced the risk of progression to type 2 diabetes among adults with prediabetes and obesity or overweight.
Related Posts
Vector Group to Sell Itself to JT Group in $2.4 Billion Deal
Tobacco company Vector Group has agreed to be acquired by Japan-based tobacco giant JT Group in a deal worth $2.4 billion.
Former Healthcare CEO Is Convicted of Plan to Conceal Insider Trading
Ex-Ontrak chairman was accused of abusing trading strategy that usually shields executives against suspicions of insider trading.
Skydance Media’s Deal to Buy Shari Redstone’s Family Company Is Back On
Skydance would pay $1.75 billion for National Amusements under the preliminary deal.